GKOS Glaukos Corporation: Prakiraan wutah bathi kanggo taun ngarep

GKOS (Glaukos Corporation) - tandha merek perusahaan

Steady demand for glaucoma treatment driven by an aging population has ensured confident growth, and the expected net income change metric has reached a peak. Currently, 107.90 records a new level mark. Glaukos Corporation (GKOS) is investing in drug delivery systems and implants, maintaining its scientific priority. Despite a narrow specialization in microsurgery, the company is successfully expanding its therapeutic platforms.

Glaukos Corp (GKOS): Prakiraan wutah bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 16.11.2026

Rincian analitis lan laporan data perusahaan Glaukos Corp (GKOS)

- rega lan prakiraan konsensus rega:
Analisis dhasar perusahaan:GKOS, Glaukos Corp
Produk merek Glaukos

This indicator measures the analysts' consensus forecast for earnings growth rates in the coming period, identifying the gap between market optimism and actual fundamental stability. The fact that Glaukos Corporation (GKOS) is operating its production capacities at full limit creates a risk of failing to meet these expectations; therefore, the projection of the company's earnings dynamics for the next year serves as a signal for a potential capital revaluation should any operational disruptions occur.

Pesaing Glaukos Corporation

ALC (Alcon Corp) - Prakiraan wutah bathi kanggo taun ngarep|Bausch + Lomb Corporation (BLCO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep APLS|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BLTE (Belite Bio Inc)|Prakiraan wutah bathi kanggo taun ngarep OCUL (Ocular Pharma)|Prakiraan wutah bathi kanggo taun ngarep Harrow Corp HROW|VRDN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|LENZ (LENZ Therapeutics) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Oculis (OCS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep EYPT (EyePoint Pharmaceuticals Inc)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kodiak Sciences Inc|Prakiraan wutah bathi resik saben saham ing taun ngarep aldeyra.com ALDX|Prakiraan wutah bathi kanggo taun ngarep KALA|IRD - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OKYO (OKYO Pharma Limited)|ADVM - Prakiraan wutah bathi saben saham kanggo taun ngarep|OTLK: Prakiraan wutah bathi saben saham kanggo taun ngarep|CLSD (Clearside) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|NBY: Prakiraan wutah bathi kanggo taun ngarep|Kiora Pharma (KPRX) - Prakiraan wutah bathi kanggo taun ngarep|ALIM (alimerasciences.com) - Prakiraan wutah bathi kanggo taun ngarep|eyenovia.com (EYEN) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GHSI|OCUP (Ocuphire) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OPT (Opthea Ltd)